UNC Lineberger Comprehensive Cancer Center and the UNC Institute for Global Health & Infectious Diseases have received a $3.7 million grant from the National Cancer Institute (NCI) to study the growing worldwide cancer problem and expand the University’s efforts in Malawi to study and treat HIV-associated cancers.
Expanded partnership between UNC Project-Malawi and Malawi College of Medicine will improve the quality of clinical training in Malawi
UNC-Project Malawi staff train Malawi College of Medicine medical students in order to approve HIV clinical care in Malawi.
The University of North Carolina at Chapel Hill is leading a consortium that will help cultivate the next generation of global health clinicians and scientists, offering a 10-month training fellowship at one of 17 sites in 13 countries in Asia, Africa, and South America.
New research finds that early weaning – stopping breastfeeding before six months – is of little, if any, protective value against HIV transmission nor is it safe for infant survival.
First results from ongoing Phase III trial show malaria vaccine candidate, RTS,S* reduces the risk of malaria by half in African children aged 5 to 17 months
The University of North Carolina at Chapel Hill enrolled 1,600 children at the study site in Lilongwe, Malawi.
UNC researchers have been awarded the prestigious Charles C. Shepard Science Award in the category of Prevention and Control by the Centers for Disease Control and Prevention for their paper titled, “Maternal or infant antiretroviral drugs to reduce HIV-1 transmission.”
UNC-led international study shows early treatment with antiretroviral therapy prevents HIV transmission
A research study led by the University of North Carolina at Chapel Hill has made a major discovery in the effort to halt the spread of HIV, the virus that causes AIDS.
The USAID-funded Lilongwe Relief Fund Trust of Malawi (LMRFT), in collaboration with the University of North Carolina (UNC) at Chapel Hill and several other public and private partners, has begun implementing the Safeguard the Family Project, which is aimed at decreasing mother-to-child transmission of HIV and reducing maternal and infant mortality.
The 18th Annual Conference on Retroviruses and Opportunistic Infections (CROI) wrapped up in Boston, Massachusetts, earlier this month, and UNC had a strong presence at this year’s conference.
By Anne McNulty (’11)
Myron Cohen, MD, addresses a satellite session on the implications of an important microbicides trial at the International AIDS Society conference
New results and next steps are the focus of the year’s most important HIV/AIDS research gathering. UNC researchers present findings on antiretroviral drugs, prevention approaches and community interventions.
UNC study: Antiretroviral drugs for mothers, nevirapine syrup for babies both effective in preventing HIV transmission through breast milk
UNC Study reveals that giving antiretroviral drugs to HIV-infected breastfeeding mothers in sub-Saharan Africa or giving an HIV-fighting syrup to their babies are both effective.
A crucial alternative to doctor monitoring in light of shortage of health care workers around the world